CHANGES IN THE MARKERS OF CARBOHYDRATE METABOLISM DURING ANTI-TUBERCULOSIS THERAPY IN TUBERCULOSIS PATIENTS WITH CONCURRENT DIABETES

The objective of the study: to study markers of carbohydrate metabolism in pulmonary tuberculosis patients with concurrent diabetes during treatment of tuberculosis.Subjects and methods. 156 pulmonary tuberculosis patients, divided into 2 groups, were examined. Group 1 included 69 (44.2%) pulmonary...

Full description

Saved in:
Bibliographic Details
Main Authors: R. Yu. Abdullaev, O. G. Komissarova, O. O. Bobina, S. V. Aleshina, A. E. Ergeshov
Format: Article
Language:Russian
Published: New Terra Publishing House 2019-02-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1214
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849771747349364736
author R. Yu. Abdullaev
O. G. Komissarova
O. O. Bobina
S. V. Aleshina
A. E. Ergeshov
author_facet R. Yu. Abdullaev
O. G. Komissarova
O. O. Bobina
S. V. Aleshina
A. E. Ergeshov
author_sort R. Yu. Abdullaev
collection DOAJ
description The objective of the study: to study markers of carbohydrate metabolism in pulmonary tuberculosis patients with concurrent diabetes during treatment of tuberculosis.Subjects and methods. 156 pulmonary tuberculosis patients, divided into 2 groups, were examined. Group 1 included 69 (44.2%) pulmonary tuberculosis patients with concurrent type 1 diabetes. Group 2 included 87 (55.8%) pulmonary tuberculosis patients with concurrent type 2 diabetes.Results. Prior to the start of anti-tuberculosis treatment, disorders of carbohydrate metabolism in type 1 diabetes patients were more expressed: there were the statistically significant higher level of glycated hemoglobin and glucosuria severity during the daytime (within 8-14 hour interval). Analysis of changes in carbohydrate metabolism markers showed that there was a gradual trend for their improvement if the treatment was effective and should treatment be failing, the disorders of carbohydrate metabolism were deteriorating.Conclusion. Tuberculosis deteriorated the severity of diabetes, especially of type 1, compromising the efficacy of antihyperglycemic therapy. A significant part of treatment failures among type 1 diabetes patients was potentially associated with the negative impact of poorly compensated diabetes.
format Article
id doaj-art-5fb8d76abd1849d7824dc36e1882ae70
institution DOAJ
issn 2075-1230
2542-1506
language Russian
publishDate 2019-02-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj-art-5fb8d76abd1849d7824dc36e1882ae702025-08-20T03:02:30ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062019-02-01971121710.21292/2075-1230-2019-97-1-12-171214CHANGES IN THE MARKERS OF CARBOHYDRATE METABOLISM DURING ANTI-TUBERCULOSIS THERAPY IN TUBERCULOSIS PATIENTS WITH CONCURRENT DIABETESR. Yu. Abdullaev0O. G. Komissarova1O. O. Bobina2S. V. Aleshina3A. E. Ergeshov4Central Tuberculosis Research InstituteCentral Tuberculosis Research Institute$ Pirogov Russian National Research Medical UniversityCentral Tuberculosis Research InstituteCentral Tuberculosis Research InstituteCentral Tuberculosis Research InstituteThe objective of the study: to study markers of carbohydrate metabolism in pulmonary tuberculosis patients with concurrent diabetes during treatment of tuberculosis.Subjects and methods. 156 pulmonary tuberculosis patients, divided into 2 groups, were examined. Group 1 included 69 (44.2%) pulmonary tuberculosis patients with concurrent type 1 diabetes. Group 2 included 87 (55.8%) pulmonary tuberculosis patients with concurrent type 2 diabetes.Results. Prior to the start of anti-tuberculosis treatment, disorders of carbohydrate metabolism in type 1 diabetes patients were more expressed: there were the statistically significant higher level of glycated hemoglobin and glucosuria severity during the daytime (within 8-14 hour interval). Analysis of changes in carbohydrate metabolism markers showed that there was a gradual trend for their improvement if the treatment was effective and should treatment be failing, the disorders of carbohydrate metabolism were deteriorating.Conclusion. Tuberculosis deteriorated the severity of diabetes, especially of type 1, compromising the efficacy of antihyperglycemic therapy. A significant part of treatment failures among type 1 diabetes patients was potentially associated with the negative impact of poorly compensated diabetes.https://www.tibl-journal.com/jour/article/view/1214tuberculosisdiabetescarbohydrate metabolismglycated hemoglobin
spellingShingle R. Yu. Abdullaev
O. G. Komissarova
O. O. Bobina
S. V. Aleshina
A. E. Ergeshov
CHANGES IN THE MARKERS OF CARBOHYDRATE METABOLISM DURING ANTI-TUBERCULOSIS THERAPY IN TUBERCULOSIS PATIENTS WITH CONCURRENT DIABETES
Туберкулез и болезни лёгких
tuberculosis
diabetes
carbohydrate metabolism
glycated hemoglobin
title CHANGES IN THE MARKERS OF CARBOHYDRATE METABOLISM DURING ANTI-TUBERCULOSIS THERAPY IN TUBERCULOSIS PATIENTS WITH CONCURRENT DIABETES
title_full CHANGES IN THE MARKERS OF CARBOHYDRATE METABOLISM DURING ANTI-TUBERCULOSIS THERAPY IN TUBERCULOSIS PATIENTS WITH CONCURRENT DIABETES
title_fullStr CHANGES IN THE MARKERS OF CARBOHYDRATE METABOLISM DURING ANTI-TUBERCULOSIS THERAPY IN TUBERCULOSIS PATIENTS WITH CONCURRENT DIABETES
title_full_unstemmed CHANGES IN THE MARKERS OF CARBOHYDRATE METABOLISM DURING ANTI-TUBERCULOSIS THERAPY IN TUBERCULOSIS PATIENTS WITH CONCURRENT DIABETES
title_short CHANGES IN THE MARKERS OF CARBOHYDRATE METABOLISM DURING ANTI-TUBERCULOSIS THERAPY IN TUBERCULOSIS PATIENTS WITH CONCURRENT DIABETES
title_sort changes in the markers of carbohydrate metabolism during anti tuberculosis therapy in tuberculosis patients with concurrent diabetes
topic tuberculosis
diabetes
carbohydrate metabolism
glycated hemoglobin
url https://www.tibl-journal.com/jour/article/view/1214
work_keys_str_mv AT ryuabdullaev changesinthemarkersofcarbohydratemetabolismduringantituberculosistherapyintuberculosispatientswithconcurrentdiabetes
AT ogkomissarova changesinthemarkersofcarbohydratemetabolismduringantituberculosistherapyintuberculosispatientswithconcurrentdiabetes
AT oobobina changesinthemarkersofcarbohydratemetabolismduringantituberculosistherapyintuberculosispatientswithconcurrentdiabetes
AT svaleshina changesinthemarkersofcarbohydratemetabolismduringantituberculosistherapyintuberculosispatientswithconcurrentdiabetes
AT aeergeshov changesinthemarkersofcarbohydratemetabolismduringantituberculosistherapyintuberculosispatientswithconcurrentdiabetes